Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

NeoGenomics : Truist Starts NeoGenomics at Buy With $65 Price Target

01/28/2021 | 07:47am EDT


ę MT Newswires 2021
All news about NEOGENOMICS, INC.
10/14Health Care Stocks Moderate Slightly in Afternoon Trading
MT
10/14NEOGENOMICS : Shares Rise After Raymond James Upgrade
MT
10/14Health Care Stocks Keeping Pace With Rising Thursday Markets
MT
10/14NEOGENOMICS : Raymond James Upgrades NeoGenomics to Outperform from Market Perform, Sets $..
MT
10/13NEOGENOMICS : Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
PU
10/12NEOGENOMICS : Appoints Lead Independent Director Lynn Tetrault as Non-Executive Chair. Dou..
PU
10/12NEOGENOMICS INC : Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
10/12NeoGenomics, Inc. Announces Board Changes
CI
10/12NEOGENOMICS : Announces Board of Directors' Transition
PU
10/01Health Care Stocks Broadly Higher Late Friday
MT
More news
Analyst Recommendations on NEOGENOMICS, INC.
More recommendations
Financials (USD)
Sales 2021 499 M - -
Net income 2021 16,5 M - -
Net Debt 2021 157 M - -
P/E ratio 2021 366x
Yield 2021 -
Capitalization 5 334 M 5 334 M -
EV / Sales 2021 11,0x
EV / Sales 2022 9,46x
Nbr of Employees 1 700
Free-Float 96,0%
Chart NEOGENOMICS, INC.
Duration : Period :
NeoGenomics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGENOMICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 43,38 $
Average target price 56,45 $
Spread / Average Target 30,1%
EPS Revisions
Managers and Directors
Mark Mallon Chief Executive Officer & Director
George A. Cardoza President & Chief Operating Officer-Lab Operations
Kathryn B. McKenzie Chief Financial Officer
Douglas M. Van Oort Executive Chairman
Steven A. Ross Chief Information Officer & Vice President
Sector and Competitors